Aldeyra Therapeu (ALDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,527 | 10,142 | 11,536 | 2,146 | 3,262 |
| TOTAL | $8,760 | $10,345 | $11,805 | $2,155 | $3,271 |
| Non-Current Assets | |||||
| PPE Net | 13 | 6 | N/A | N/A | N/A |
| Other Non-Current Assets | 14 | 0 | 0 | 735 | 473 |
| TOTAL | $27 | $6 | $N/A | $735 | $473 |
| Total Assets | $8,787 | $10,351 | $11,805 | $2,891 | $3,743 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 78 | N/A | 407 | 233 | 58 |
| Accounts payable and accrued liabilities | 341 | 483 | 556 | 166 | 342 |
| Accrued Expenses | 909 | 364 | 211 | 133 | 118 |
| TOTAL | $1,328 | $846 | $1,175 | $692 | $605 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,176 | 1,241 | 816 | 972 | 1,129 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 1,759 | 3,519 |
| TOTAL | $1,176 | $1,241 | $816 | $3,336 | $5,042 |
| Total Liabilities | $2,503 | $2,087 | $1,990 | $4,027 | $5,647 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,890 | 5,565 | 5,565 | 5,565 | N/A |
| Common Shares | 6 | 6 | 6 | 0 | 0 |
| Retained earnings | -46,512 | -44,067 | -42,058 | -40,923 | -41,324 |
| Other shareholders' equity | 0 | 0 | 0 | 38,509 | 38,317 |
| TOTAL | $6,284 | $8,264 | $9,815 | $-1,137 | $-1,904 |
| Total Liabilities And Equity | $8,787 | $10,351 | $11,805 | $2,891 | $3,743 |